Sep 30, 2022
- Sep 29, 2023

Accurate Diagnosis and Emerging Neutrophil Serine Protease Therapeutics for Patients with Non-Cystic Fibrosis Bronchiectasis

EARNed Credits

0.75

AMA PRA Category 1 CreditTM

Screen-Shot-2022-09-27-at-11.50.25-AM

Overview

This CME program is derived from content presented at the 2022 Eastern Pulmonary Conference. The expert faculty, Dr. Gregory Tino, will first outline the pathophysiology, prevalence and radiological distribution of non-cystic fibrosis bronchiectasis (NCFBE). Current treatment guidelines and recommendations for patients with NCFBE will be reviewed and an overview of phenotyping provided. Dr. Tino will conclude with an analysis of current trial data, including a discussion of practical implications for clinicians who treat and manage patients with non-cystic fibrosis bronchiectasis.

Who Should Attend

Pulmonologists, primary care physicians, radiologists, advanced practitioners, and other healthcare professionals who care for patients with NCFBE

Provided By

Course Faculty

Sidney S. Braman, MD
Professor of Medicine, Emeritus Icahn School of Medicine at Mount Sinai New York, NY
Gregory Tino, MD
Associate Professor of Medicine Hospital of the University of Pennsylvania Philadelphia, Pennsylvania

Learning Objectives

1

Understand the science of NCFBE, including disease burden, unmet needs, patient risk factors and comorbidities, and early and accurate diagnostic techniques that can reduce treatment delays

2

Review NCFBE pathophysiology, natural history and clinical progression

3

Analyze the role of neutrophilic inflammation and neutrophil serine proteases in NCFBE and review clinical trial data on dipeptidyl peptidase 1 (DPP1) therapeutics.

Additional Course Information

It is the policy of AcademicCME that all faculty, instructors, and planners disclose relevant financial relationships relating to the topics of this educational activity. Any relevant financial relationships are mitigated via a content review by planning committee members and faculty with no relevant financial relationships.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity:

Faculty Relationship Identified With:
Sidney S. Braman, MD Nothing to disclose
Gregory Tino, MD Consultant/Advisor: AstraZeneca; Insmed

Timothy Hayes, MD, PhD; Kim Cheramie, MSN, RN-BC; Nicole McMenamin and Chelsey Benedek hereby state that they or their spouse/life partner do not have any relevant financial relationships to products or devices with any commercial interests related to the content of this activity of any amount during the past 12 months.

In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AcademicCME designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits TM.

Clinicians should only claim credit commensurate with the extent of their participation.

This activity has been supported by an independent educational grant from Insmed.

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. AcademicCME and Insmed do not recommend the use of any agent outside of the labeled indications.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

In order to claim credit, participants must complete the following:

  1. Read the learning objectives, accreditation information and faculty disclosures at the beginning of this activity.
  2. Complete the Pre-Activity Questions
  3. Read or Review the activity content.
  4. Complete the Post-Activity Test Questions and Evaluation.
  5. Learners who receive a grade of 60% or better on the Post-Activity Test Questions and complete the Evaluation will receive appropriate credit as indicated (CME, CNE, and/or CPE credit).
  • CPE credit will be posted to the learner’s CPE Monitor profile within 60 days of completion.
  • CME and CNE credit will be issued appropriate certificate of completion.
  • Others may request a “certificate of completion”.
  1. Learners should claim only the credit commensurate with the extent of their participation in the activity.

For all CE inquiries or special needs, please contact [email protected].

Sep 30, 2022
- Sep 29, 2023

Accurate Diagnosis and Emerging Neutrophil Serine Protease Therapeutics for Patients with Non-Cystic Fibrosis Bronchiectasis

Related Webcast Courses

Pulmonology
Accurate Diagnosis and Guideline-Driven Individualized Treatment Plans to Manage Patients ...
Pulmonology
Case-Based Learning on Optimal Immuno-Oncologic Management of Extensive-Stage Small Cell L...
Pulmonology
Update on Best Practices for the Prompt and Personalized Management of Patients with COPD ...